SLC7A11 and pancreatic neoplasm: Since SLC7A11-AS1 could stabilize NRF2 in pancreatic cancer (Yang et al., 2020) and SLC7A11 is also a common target of NRF2 (Fan et al., 2017), we further analyzed the effect of SLC7A11-AS1 on the NRF2 expression.